OUTLINE: This is an observational study.
Patients undergo blood sample collection and complete surveys on study. Patients' medical records are also reviewed.
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Subjects who have or have had ovarian, peritoneal, or fallopian tube carcinoma who have a life expectancy of greater than 6 months and:
* Have completed or plan to complete at least 5 cycles of platinum-based chemotherapy
OR
Subjects who have or have had a solid tumor diagnosis and any of the following:
* At least 4 months of exposure to a PARP inhibitor
* Diagnosis of a blood disorder including, but not limited to, clonal hematopoiesis of indeterminate potential, cytopenia of unknown significance, or therapy-related myeloid neoplasm
You may not be if
Individuals with a life expectancy of less than 6 months
